A White House official announced on Thursday, December 14, that twenty-eight health insurance companies, including CVS Health, are signing voluntary commitments initiated by President Joe Biden's administration aimed at ensuring the safe development of artificial intelligence. According to Reuters, the commitments of the insurance companies and insured parties are subject to the commitments of 15 leading AI companies, including Google, OpenAI, and its partner Microsoft, for the responsible development of AI models. The Biden administration is working to establish AI-related characteristics as quickly as possible because the capabilities and popularity of AI are rapidly expanding while the associated rules and regulations remain limited. The unnamed White House official stated, "The government is leveraging its tools to develop responsible AI in health-related fields," adding that AI, if managed responsibly, has significant potential to benefit patients, doctors, and hospital staff. On October 30, Joe Biden issued an executive order requiring AI system producers that may pose risks to national security, the economy, public health, or safety to share safety test results with the government before publicly releasing these systems. The White House official remarked, "We must be vigilant to realize AI's promise in improving health outcomes," and added, "Without proper testing, risk mitigation methods, and human oversight, AI-equipped tools used for clinical decision-making can produce errors that, at best, are costly and, at worst, dangerous." They also noted that without adequate oversight, AI diagnoses based on gender and race could be biased, especially when the AI has not been trained on data relevant to the studied population. The U.S. government's program is based on principles that require companies to inform users if they receive content primarily generated by AI that has not been reviewed and edited by individuals, and to monitor and address the harms these programs may cause. The signing companies commit to using AI responsibly and finding solutions to enhance health equity, expand access to healthcare, make it affordable, and coordinate care to improve outcomes, reduce burnout among healthcare workers, and enhance patient experience. The end of the AI Safety Summit in London saw a global agreement to address potential AI risks, with representatives from 28 countries agreeing to contain "AI risks." Elham Tabasi was selected as one of the 100 influential figures in AI worldwide. Google stated that in "political advertising," everyone "must" disclose AI tools. Pope Francis warned of the potential dangers of AI. The White House secured commitments from American tech giants regarding AI. The potential for legal violations is being examined; "ChatGPT" is under scrutiny by the U.S. Federal Trade Commission. The White House is reporting on AI to the U.S. Senate.
Health Insurance Companies Join Biden Administration's AI Risk Management Program
Twenty-eight health insurance companies, including CVS Health, are signing voluntary commitments to ensure the safe development of AI as part of a Biden administration initiative. This move aims to establish responsible AI practices in healthcare amidst growing concerns about AI's rapid expansion and potential risks. The initiative highlights the importance of oversight and responsible use of AI in improving health outcomes.
👥 Key Players
📰 What Happened
Twenty-eight health insurance companies, including CVS Health, have signed voluntary commitments to ensure the safe development of AI as part of a Biden administration initiative. This initiative aims to establish responsible AI practices in healthcare amidst growing concerns about AI's rapid expansion and potential risks.
- The commitments are part of a broader effort to ensure AI's responsible use in health-related fields.
- An executive order requires AI producers to share safety test results with the government before releasing their systems.
💡 Why It Matters
📚 Background
AI technology is rapidly evolving, raising concerns about safety, bias, and ethical use, particularly in sensitive areas like healthcare.
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%